Jynarque
Ended Awarded Last action
- Contract number
- 36C26120N0588
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $50,241
Award facts
- Contract value 100% obligated
- $50,240.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$10,372 | |
| Original award | $60,613 |
About this award
Otsuka America Pharmaceutical Inc. received a $50.2K firm-fixed-price delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 21 for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. Awarded on April 13, 2020, with completion targeted for July 9, 2020, this delivery order was issued without set-aside designation and performed in Pittsburgh, Pennsylvania. The award represents part of the VA's ongoing procurement of critical medications through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
This delivery order was issued under Otsuka America Pharmaceutical Inc.'s broader Indefinite Delivery Vehicle relationship with the VA, specifically an $83.3M Blanket Purchase Agreement for Jynarque that extends through March 2026. The company maintains substantial federal supply schedules totaling approximately $396M for pharmaceuticals and hematology-related products, enabling streamlined procurement across multiple VA Integrated Service Networks nationwide. These arrangements facilitate efficient distribution of specialized pharmaceutical treatments to veterans requiring complex medical interventions across the Veterans Health Administration system.
Quick answers
Who was awarded contract 36C26120N0588?
36C26120N0588 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 13, 2020.
How much is contract 36C26120N0588 worth?
The government has obligated $50,241 on 36C26120N0588.
Is contract 36C26120N0588 an order under another contract?
Yes. 36C26120N0588 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26120N0588 competed?
The extent of competition for 36C26120N0588 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award